Doseology Sciences Inc. announces the appointment of Harbir Toor as Director and Independent Audit Chair, effective January 27, 2022. Ms. Toor has 25 years of experience in strategic planning, risk management, governance, capital raises, and financial accounting. Ms. Marissen thanks Interim CFO Alex McAulay for his service to the Company.

Doseology also announces that Mr. Gordon Jang has resigned as a Director and Independent Audit Chair of the Company, effective January 27, 2022. Mr. Jang will remain an advisor on Doseology's financial matters and strategic decisions. Doseology wishes to thank Gordon for his valuable service and insight.